Schedule 13D ownership disclosure
Merrimack Pharmaceuticals Inc
Security class unavailable · CUSIP: 590328209
Event date: 2023-01-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-003744
- Form type
- SC 13D
- Filer
- MERRIMACK PHARMACEUTICALS INC
- CIK
- CIK 1274792
- Filed
- Jan 25, 2024
- Reporting period
- Jan 17, 2023
- Description
- Schedule 13D beneficial ownership